What is she best known for?
The fields of study she is best known for:
- Neuron
- Dopamine
- Neurotransmitter
Veronica Ghiglieri mainly investigates Neuroscience, Synaptic plasticity, Long-term potentiation, Parkinson's disease and Dyskinesia.
Neuroscience connects with themes related to NMDA receptor in her study.
The concepts of her Synaptic plasticity study are interwoven with issues in Basal ganglia and Abnormal involuntary movement.
Her Long-term potentiation research includes elements of Glutamate receptor, Hippocampus and Hippocampal formation.
Her research investigates the link between Dyskinesia and topics such as Levodopa that cross with problems in Postsynaptic potential.
Her study in Medium spiny neuron is interdisciplinary in nature, drawing from both Muscarinic acetylcholine receptor, Cholinergic, Indirect pathway of movement, Function and Direct pathway of movement.
Her most cited work include:
- Direct and indirect pathways of basal ganglia: a critical reappraisal (398 citations)
- Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap (265 citations)
- A Critical Interaction between NR2B and MAGUK in l-DOPA Induced Dyskinesia (221 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Neuroscience, Synaptic plasticity, Long-term potentiation, Dopamine and Parkinson's disease.
The study incorporates disciplines such as NMDA receptor and Dyskinesia in addition to Neuroscience.
Her studies deal with areas such as Levodopa and Excitatory postsynaptic potential as well as Dyskinesia.
Her research integrates issues of Neuroplasticity, Dopamine receptor D2, Long-term depression and Abnormal involuntary movement in her study of Synaptic plasticity.
Her Long-term potentiation research is multidisciplinary, incorporating elements of Glutamate receptor, Hippocampus, Neurotransmission and Depotentiation.
The various areas that Veronica Ghiglieri examines in her Parkinson's disease study include Neuroinflammation, Stimulation and Parkinsonism.
She most often published in these fields:
- Neuroscience (85.53%)
- Synaptic plasticity (56.58%)
- Long-term potentiation (48.68%)
What were the highlights of her more recent work (between 2018-2021)?
- Dopamine (32.89%)
- Neuroscience (85.53%)
- Medium spiny neuron (25.00%)
In recent papers she was focusing on the following fields of study:
Veronica Ghiglieri mainly focuses on Dopamine, Neuroscience, Medium spiny neuron, Parkinson's disease and Striatum.
As a member of one scientific family, Veronica Ghiglieri mostly works in the field of Dopamine, focusing on Long-term potentiation and, on occasion, Glutamate receptor.
Her work carried out in the field of Medium spiny neuron brings together such families of science as NMDA receptor, Pharmacology, Synaptic plasticity and Abnormal involuntary movement.
Her NMDA receptor research integrates issues from Huntington's disease, Dyskinesia, Levodopa-induced dyskinesia and Synaptic scaling.
Her studies in Parkinson's disease integrate themes in fields like Inflammation, Neuroinflammation, Microglia and Neuron.
Her research investigates the connection with Striatum and areas like Basal ganglia which intersect with concerns in Dopaminergic, Neurotransmission and Motor learning.
Between 2018 and 2021, her most popular works were:
- Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease (40 citations)
- Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration (19 citations)
- NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology. (9 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
